Kymera Therapeutics Inc. (KYMR)
30.14
-1.21 (-3.86%)
At close: Mar 03, 2025, 3:59 PM
30.17
0.10%
After-hours: Mar 03, 2025, 04:00 PM EST
Kymera Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 120.26M | 109.97M | 68.39M | 47.98M | 31M | 76.02M | 41.26M |
| Short-Term Investments | 368.49M | 264.92M | 338.77M | 394.44M | 265.2M | 15.94M | n/a |
| Long-Term Investments | n/a | 61.43M | 152.33M | 125.19M | 162.53M | 1.77M | 199K |
| Other Long-Term Assets | 369.9M | 7.93M | -122.02M | -98.77M | 11.46M | n/a | n/a |
| Receivables | 947K | 18.76M | 2.54M | 135K | 1.43M | n/a | 148K |
| Inventory | n/a | n/a | -12.25M | -8.99M | -163.39M | n/a | n/a |
| Other Current Assets | 20.58M | 11.67M | 9.71M | 8.72M | 4.7M | 888K | 382K |
| Total Current Assets | 510.27M | 405.32M | 559.49M | 567.61M | 302.34M | 92.84M | 41.79M |
| Property-Plant & Equipment | 97.86M | 101.08M | 13.33M | 11.88M | 10.84M | 22.08M | 2.24M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 467.77M | 170.44M | 43.64M | 38.3M | 184.84M | 23.86M | 2.44M |
| Total Assets | 978.03M | 575.76M | 603.13M | 605.9M | 487.18M | 116.7M | 44.23M |
| Account Payables | 5.99M | 7.08M | 4.33M | 4M | 4.37M | 3.28M | 2.06M |
| Deferred Revenue | 13.58M | 37.88M | 63.26M | 101.03M | 170.39M | 23.35M | 2.32M |
| Short-Term Debt | 13.11M | 6.34M | 7.89M | 7.2M | 6.52M | 3.38M | 302K |
| Other Current Liabilities | 35.09M | 34.39M | 23.86M | 19.6M | 7.17M | 4.57M | 2.33M |
| Total Current Liabilities | 67.77M | 85.69M | 63.26M | 101.03M | 110.62M | 34.57M | 4.69M |
| Long-Term Debt | 74.65M | 78.33M | 26.78M | 28.73M | 29.46M | 17.82M | 393K |
| Other Long-Term Liabilities | n/a | n/a | -13.14M | -14.3M | -14.63M | 109.08M | 73.59M |
| Total Long-Term Liabilities | 74.65M | 95.1M | 49.72M | 45.23M | 92.67M | 156.54M | 73.98M |
| Total Liabilities | 142.42M | 180.79M | 112.98M | 146.27M | 203.29M | 191.11M | 78.67M |
| Total Debt | 87.76M | 84.67M | 17.34M | 17.96M | 17.99M | 21.19M | 695K |
| Common Stock | 7K | 6K | 6K | 5K | 4K | n/a | n/a |
| Retained Earnings | -754.61M | -530.75M | -383.79M | -228.98M | -128.76M | -76.46M | -35.21M |
| Comprehensive Income | -1.49M | -552K | -4.95M | -660K | -128K | 6K | n/a |
| Shareholders Equity | 835.62M | 394.97M | 490.15M | 459.64M | 283.89M | -74.41M | -34.44M |
| Total Investments | 368.49M | 326.35M | 491.1M | 519.63M | 427.73M | 15.94M | 199K |